Eurointervention最新文献

筛选
英文 中文
Aspirin withdrawal after primary PCI for STEMI: timing matters. STEMI患者首次PCI后阿司匹林停药:时机问题。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-20 DOI: 10.4244/EIJ-E-26-00010
Valeria Paradies, Giandomenico Mancini
{"title":"Aspirin withdrawal after primary PCI for STEMI: timing matters.","authors":"Valeria Paradies, Giandomenico Mancini","doi":"10.4244/EIJ-E-26-00010","DOIUrl":"10.4244/EIJ-E-26-00010","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 14","pages":"e760-e761"},"PeriodicalIF":9.2,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13358691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148521417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trial. 原发性经皮冠状动脉介入治疗后替格瑞洛单药治疗与双重抗血小板治疗:STOP-IMH随机试验的1年结果
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-20 DOI: 10.4244/EIJ-D-26-00421
Bahram Yosofi, Eva C I Woelders, Denise A M Peeters, Clemens von Birgelen, Johannes B van Rees, Antonius A C M Heestermans, Bimmer E P M Claessen, Stijn C H van den Oord, Maurits T Dirksen, Daphne van Vliet, Lara S F Konijnenberg, Aysun Cetinyurek-Yavuz, Niels van Royen, Robert-Jan M van Geuns, Robin Nijveldt, Peter Damman
{"title":"Ticagrelor monotherapy versus dual antiplatelet therapy after primary percutaneous coronary intervention: one-year outcomes of the pilot STOP-IMH randomised trial.","authors":"Bahram Yosofi, Eva C I Woelders, Denise A M Peeters, Clemens von Birgelen, Johannes B van Rees, Antonius A C M Heestermans, Bimmer E P M Claessen, Stijn C H van den Oord, Maurits T Dirksen, Daphne van Vliet, Lara S F Konijnenberg, Aysun Cetinyurek-Yavuz, Niels van Royen, Robert-Jan M van Geuns, Robin Nijveldt, Peter Damman","doi":"10.4244/EIJ-D-26-00421","DOIUrl":"10.4244/EIJ-D-26-00421","url":null,"abstract":"<p><strong>Background: </strong>Ticagrelor monotherapy after a short period of dual antiplatelet therapy (DAPT) has been shown to be safe and effective after percutaneous coronary intervention (PCI), including primary PCI for patients with ST-segment elevation myocardial infarction (STEMI). However, the omission of aspirin could further reduce bleeding risk.</p><p><strong>Aims: </strong>We aimed to assess the impact of ticagrelor monotherapy directly after primary PCI in terms of ischaemic events and to investigate the effect on clinical bleeding events.</p><p><strong>Methods: </strong>In this multicentre, open-label pilot study, 200 STEMI patients were randomised 1:1 to ticagrelor monotherapy versus ticagrelor plus aspirin, directly after primary PCI. Major adverse cardiac and cerebrovascular events (MACCE) and bleeding were assessed at 13 months. The incidence of intramyocardial haemorrhage (IMH) was compared between groups.</p><p><strong>Results: </strong>In the ticagrelor monotherapy group (n=98) and DAPT group (n=101), MACCE occurred in 4.1% versus 4.0%, respectively (hazard ratio [HR] 1.04, 95% confidence interval [CI]: 0.26-4.17). Clinically relevant bleeding was observed in 4.1% versus 10.9% (HR 0.37, 95% CI: 0.12-1.17), and clinically relevant non-access site bleeding in 2.0% versus 9.9% (HR 0.20, 95% CI: 0.04-0.92).</p><p><strong>Conclusions: </strong>While no significant difference in ischaemic events was observed between ticagrelor monotherapy and DAPT in the first 13 months after primary PCI, this pilot study was underpowered to confirm efficacy. In addition, non-access site bleeding events were significantly reduced, and there was a downward trend in all clinical bleeding events. The incidence of IMH was similar between groups. (ClinicalTrials.gov: NCT05986968).</p>","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":" ","pages":"e773-e783"},"PeriodicalIF":9.2,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13358696/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148037606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collapse of a new-generation magnesium scaffold. 新一代镁支架的坍塌。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-20 DOI: 10.4244/EIJ-D-25-00731
Teresa Bastante, Javier Cuesta, Fernando Alfonso
{"title":"Collapse of a new-generation magnesium scaffold.","authors":"Teresa Bastante, Javier Cuesta, Fernando Alfonso","doi":"10.4244/EIJ-D-25-00731","DOIUrl":"10.4244/EIJ-D-25-00731","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 14","pages":"e798-e799"},"PeriodicalIF":9.2,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13358699/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148521376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endotype-guided medical therapy and symptom response in ANOCA. 内源性引导的药物治疗与ANOCA的症状反应。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-20 DOI: 10.4244/EIJ-D-26-00148
Jacopo Farina, Sant Kumar, Gianluca Campo, Simone Biscaglia, Alberto Sarti, Joan Llevadot-Sesmilo, Valeria Paradies, Gianluca Mincione, Brian Christopher Case, Antonio Maria Leone, Domenico Galante, Andrea Erriquez, Salvatore Brugaletta
{"title":"Endotype-guided medical therapy and symptom response in ANOCA.","authors":"Jacopo Farina, Sant Kumar, Gianluca Campo, Simone Biscaglia, Alberto Sarti, Joan Llevadot-Sesmilo, Valeria Paradies, Gianluca Mincione, Brian Christopher Case, Antonio Maria Leone, Domenico Galante, Andrea Erriquez, Salvatore Brugaletta","doi":"10.4244/EIJ-D-26-00148","DOIUrl":"10.4244/EIJ-D-26-00148","url":null,"abstract":"<p><strong>Background: </strong>Invasive coronary functional testing enables the classification of angina with non-obstructive coronary arteries (ANOCA) into distinct endotypes. However, real-world data linking endotype identification to subsequent pharmacological management and patient-reported symptom outcomes remain limited.</p><p><strong>Aims: </strong>We sought to evaluate the association between coronary endotypes, post-testing pharmacological treatment patterns, and changes in angina-related quality of life in patients with ANOCA in a multicentre real-world registry.</p><p><strong>Methods: </strong>Consecutive ANOCA patients undergoing invasive coronary functional testing were included. Patients were classified into six endotypes using adenosine- and acetylcholine-based testing. Pharmacological therapy was adjusted at the discretion of the treating physician based on the functional test results. The primary endpoint was a clinically meaningful improvement in angina-related health status, defined as a ≥5-point increase in the 7-item Seattle Angina Questionnaire (SAQ-7) summary score, assessed within each endotype.</p><p><strong>Results: </strong>Among 525 patients, endotype distribution was as follows: normal physiology 10.5%, elevated resting coronary blood flow 8.8%, high resistance 13.9%, compensated high resistance 14.9%, epicardial spasm 33.3%, and microvascular spasm 18.7%. After testing, prescription patterns differed across the endotypes, with increased use of beta blockers, ranolazine, and renin-angiotensin-aldosterone system blockers in coronary microvascular dysfunction endotypes and greater use of non-dihydropyridine calcium channel blockers in vasospastic endotypes. At follow-up, a ΔSAQ-7 summary score ≥5 points was observed in elevated resting flow, high-resistance, compensated high-resistance, and epicardial spasm endotypes (all p<0.001) but not in microvascular spasm or normal physiology.</p><p><strong>Conclusions: </strong>In this multicentre real-world registry, invasive coronary endotyping was associated with distinct pharmacological management patterns and differential changes in angina-related quality of life across ANOCA endotypes.</p>","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 14","pages":"e784-e794"},"PeriodicalIF":9.2,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13358701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148521399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When less is no longer more: very early aspirin discontinuation after ACS. 当“少”不再是“多”时:ACS后很早就停用阿司匹林。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-20 DOI: 10.4244/EIJ-D-26-00648
Raffaele Piccolo, Antonio Pio Vitale
{"title":"When less is no longer more: very early aspirin discontinuation after ACS.","authors":"Raffaele Piccolo, Antonio Pio Vitale","doi":"10.4244/EIJ-D-26-00648","DOIUrl":"10.4244/EIJ-D-26-00648","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 14","pages":"e757-e759"},"PeriodicalIF":9.2,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13358694/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148521350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention. 经皮冠状动脉介入治疗后残存或复发心绞痛患者血管舒缩功能障碍的发生率。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-20 DOI: 10.4244/EIJ-D-25-01215
Caïa Crooijmans, Tijn P J Jansen, Behruz Yosofi, Fleur W Adriaansen, Joan G Meeder, Wouter S Remkes, Marcel A M Beijk, Yolande Appelman, Tim P van de Hoef, Annemiek de Vos, Valeria Paradies, Martijn Meuwissen, Nicola S Vos, Els G M Olde Bijvank, Michael Magro, Stijn C H van den Oord, Karin E Arkenbout, Ton A A C M Heestermans, Marlies M Kok, Pier Woudstra, Melina C den Haan, Patty Winkler, Arnoud van 't Hof, Hester M den Ruijter, Aysun Cetinyurek-Yavuz, Niels van Royen, Suzette Elias-Smale, Aukelien C Dimitriu-Leen, Peter Damman, On Behalf Of The Nl-Cft Investigators
{"title":"Prevalence of vasomotor dysfunction in patients with residual or recurrent angina after percutaneous coronary intervention.","authors":"Caïa Crooijmans, Tijn P J Jansen, Behruz Yosofi, Fleur W Adriaansen, Joan G Meeder, Wouter S Remkes, Marcel A M Beijk, Yolande Appelman, Tim P van de Hoef, Annemiek de Vos, Valeria Paradies, Martijn Meuwissen, Nicola S Vos, Els G M Olde Bijvank, Michael Magro, Stijn C H van den Oord, Karin E Arkenbout, Ton A A C M Heestermans, Marlies M Kok, Pier Woudstra, Melina C den Haan, Patty Winkler, Arnoud van 't Hof, Hester M den Ruijter, Aysun Cetinyurek-Yavuz, Niels van Royen, Suzette Elias-Smale, Aukelien C Dimitriu-Leen, Peter Damman, On Behalf Of The Nl-Cft Investigators","doi":"10.4244/EIJ-D-25-01215","DOIUrl":"10.4244/EIJ-D-25-01215","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 14","pages":"e795-e797"},"PeriodicalIF":9.2,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13358695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148521363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure. 主播与守望者2.5:左心耳闭合的随机比较。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-06 DOI: 10.4244/EIJ-D-26-00453
Philippe Garot, Jens Erik Nielsen-Kudsk
{"title":"AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure.","authors":"Philippe Garot, Jens Erik Nielsen-Kudsk","doi":"10.4244/EIJ-D-26-00453","DOIUrl":"10.4244/EIJ-D-26-00453","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 13","pages":"e715-e716"},"PeriodicalIF":9.2,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13330108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148392569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial. 假体与患者与环内自膨胀瓣膜的不匹配:PORTICO IDE试验的分析。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-06 DOI: 10.4244/EIJ-D-26-00158
Gregory P Fontana, Ron Waksman, Arash Salemi, Marc Cohen, William Abernethy, James Hermiller, Craig Baker, Joseph Montarello, Neal Kleiman, Lars Sondergaard, Eric Gnall, Roberto Rodriguez, Hemal Gada, William Brinkman, Neil J Weissman, Paul Mahoney, Raj Makkar
{"title":"Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial.","authors":"Gregory P Fontana, Ron Waksman, Arash Salemi, Marc Cohen, William Abernethy, James Hermiller, Craig Baker, Joseph Montarello, Neal Kleiman, Lars Sondergaard, Eric Gnall, Roberto Rodriguez, Hemal Gada, William Brinkman, Neil J Weissman, Paul Mahoney, Raj Makkar","doi":"10.4244/EIJ-D-26-00158","DOIUrl":"10.4244/EIJ-D-26-00158","url":null,"abstract":"<p><strong>Background: </strong>Aortic valve replacement in small aortic annuli is associated with an increased risk of impaired haemodynamics.</p><p><strong>Aims: </strong>We sought to evaluate haemodynamic outcomes and prosthesis-patient mismatch (PPM) in aortic stenosis (AS) patients treated with Portico, Evolut, and SAPIEN 3 transcatheter aortic valves (TAVs) in small (diameter ≤23 mm) and large (diameter >23 mm) aortic annuli.</p><p><strong>Methods: </strong>PORTICO IDE was a prospective, multicentre, international, premarket randomised controlled trial comparing Portico to Evolut and SAPIEN 3 TAVs. An independent core laboratory evaluated the mean transvalvular pressure gradient (MG) and the effective orifice area (EOA), and PPM was calculated based on the core lab results.</p><p><strong>Results: </strong>A total of 675 patients with severe AS at high or extreme surgical risk were included (Portico: 362 patients; Evolut: 109; SAPIEN 3: 204). At 30 days, the EOA and rates of severe PPM in small aortic annuli were similar between Portico and Evolut (EOA 1.65 cm<sup>2</sup> vs 1.78 cm<sup>2</sup>; p=0.09; PPM 3.3% vs 3.0%; p=1.0) with a higher MG (8.5 mmHg vs 6.9 mmHg; p=0.034) for Portico. No significant differences were observed between Portico and Evolut for large aortic annuli (MG 8.3 mmHg vs 7.4 mmHg; p=0.069; EOA 1.93 cm<sup>2</sup> vs 2.02 cm<sup>2</sup>; p=0.18; PPM 5.4% vs 3.2%; p=0.83). Portico was superior to SAPIEN 3 in both small (MG 8.5 mmHg vs 13.7 mmHg; p<0.0001; EOA 1.65 cm<sup>2</sup> vs 1.40 cm<sup>2</sup>; p<0.0001; PPM 3.3% vs 26.3%; p<0.0001) and large annuli (MG 8.3 mmHg vs 10.9 mmHg; p<0.0001; EOA 1.93 cm<sup>2</sup> vs 1.67 cm<sup>2</sup>; p<0.0001; PPM 5.4% vs 10.9%; p=0.0014). At 5 years, the rate of structural valve deterioration in patients with small aortic annuli was significantly lower in patients treated with Portico (2.2%) versus SAPIEN 3 (13.9%; p=0.03).</p><p><strong>Conclusions: </strong>Haemodynamic performance was similar for the intra-annular Portico and supra-annular Evolut. Portico haemodynamics outperformed the balloon-expandable SAPIEN 3 for PPM and mean gradient in both small and large aortic annuli.</p>","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 13","pages":"e741-e747"},"PeriodicalIF":9.2,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13330121/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148392577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations. 比较经导管主动脉瓣:是时候超越简单分类了。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-06 DOI: 10.4244/EIJ-E-26-00011
Daniel J Blackman, Annette Maznyczka
{"title":"Comparing transcatheter aortic valves: time to look beyond simplistic categorisations.","authors":"Daniel J Blackman, Annette Maznyczka","doi":"10.4244/EIJ-E-26-00011","DOIUrl":"10.4244/EIJ-E-26-00011","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 13","pages":"e717-e719"},"PeriodicalIF":9.2,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13330116/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148392593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant transfemoral aortic and mitral valve replacement. 合并经股主动脉瓣和二尖瓣置换术。
IF 9.2 1区 医学
Eurointervention Pub Date : 2026-07-06 DOI: 10.4244/EIJ-D-26-00128
Ioannis Lianos, Tiffany Patterson, Karine Grigoryan, Bushra Rana, Simon Redwood
{"title":"Concomitant transfemoral aortic and mitral valve replacement.","authors":"Ioannis Lianos, Tiffany Patterson, Karine Grigoryan, Bushra Rana, Simon Redwood","doi":"10.4244/EIJ-D-26-00128","DOIUrl":"10.4244/EIJ-D-26-00128","url":null,"abstract":"","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"22 13","pages":"e754-e756"},"PeriodicalIF":9.2,"publicationDate":"2026-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13330111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148392556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书